Skip to content
healthcare.dev

Redicare Nasal and Sinus Decongestant

NDC 71105-272, Redicare Nasal and Sinus Decongestant, tablet, from Redicare LLC.

Product NDC
71105-272
Status
Listed
Labeler
Redicare LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M012
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71105-272 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PHENYLEPHRINE HYDROCHLORIDE10 mg/1

Pharmacologic classes

Adrenergic alpha1-Agonists [MoA]; alpha-1 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
71105-272-027110502720250 PACKET in 1 BOX (71105-272-02) / 2 TABLET in 1 PACKET (71105-272-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 71105-272 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71105-272 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71105-272. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.